about
Cross-species transmission of a novel adenovirus associated with a fulminant pneumonia outbreak in a new world monkey colonyViral Infection in the Development and Progression of Pediatric Acute Respiratory Distress SyndromeMolecular detection and quantitative analysis of the entire spectrum of human adenoviruses by a two-reaction real-time PCR assay.Detection of antibodies against adenovirus protein IX, fiber, and hexon in human sera by immunoblot assay.Mouse adenovirus type 1 infection in SCID mice: an experimental model for antiviral therapy of systemic adenovirus infections.PCR analysis of egyptian respiratory adenovirus isolates, including identification of species, serotypes, and coinfections.Fatal disseminated mouse adenovirus type 1 infection in mice lacking B cells or Bruton's tyrosine kinase.Phylogenetic analysis of the main neutralization and hemagglutination determinants of all human adenovirus prototypes as a basis for molecular classification and taxonomy.Community respiratory virus infections following lung transplantation.Pulmonary immunity to viral infection: adenovirus infection of lung dendritic cells renders T cells nonresponsive to interleukin-2Replication properties of human adenovirus in vivo and in cultures of primary cells from different animal speciesSevere community-acquired adenovirus pneumonia in an immunocompetent 44-year-old woman: a case report and review of the literature.Quantitative detection and rapid identification of human adenoviruses.Monitoring of adenovirus infection in pediatric transplant recipients by quantitative PCR: report of six cases and review of the literature.Contribution of a single host genetic locus to mouse adenovirus type 1 infection and encephalitis.Achievements and challenges in antiviral drug discovery.Pre-Transplant Screening for Latent Adenovirus in Donors and Recipients.Fatal adenovirus encephalomyeloradiculitis in an umbilical cord stem cell transplant recipientNovel immunocompetent murine tumor model for evaluation of conditionally replication-competent (oncolytic) murine adenoviral vectors.Management of adenovirus in children after allogeneic hematopoietic stem cell transplantation.Genotyping of human adenoviruses circulating in Southwest India.Use of cidofovir in pediatric patients with adenovirus infection.Extensive cross-reactivity of CD4+ adenovirus-specific T cells: implications for immunotherapy and gene therapy.Frequency, proliferation, and activation of human memory T cells induced by a nonhuman adenovirus.Outbreak of human adenovirus type 3 infection in a pediatric long-term care facility--Illinois, 2005.Adenovirus infection in hospitalized immunocompetent children.Comparison of HSV-1 thymidine kinase-dependent and -independent inhibition of replication-competent adenoviral vectors by a panel of drugs.Fulminant isolated adenovirus hepatitis 5 months after haplo-identical HSCT for AML.Concurrent Acute Necrotizing Adenovirus Hepatitis and Enterocolitis in an Adult Patient After Double Cord Blood Stem Cell Transplant for Refractory Crohn's Disease.Internally controlled real-time PCR monitoring of adenovirus DNA load in serum or plasma of transplant recipientsMouse adenovirus type 1 infection of macrophages.Adenovirus respiratory infection: significant increase in diagnosis using PCR comparing with antigen detection and culture methods.Capture and generation of adenovirus specific T cells for adoptive immunotherapy.Severe pneumonia caused by adenovirus 7 in pregnant woman: Case report and review of the literature.Adenoviral infection in hematopoietic stem cell transplantation: early diagnosis with quantitative detection of the viral genome in serum and urine.
P2860
Q21090496-F4A8A3D9-9359-4BF7-8A7E-EBDF75EA7F0CQ28071857-09C675D7-E95F-4FC5-9557-B96ADC10A992Q33885095-BCD283A0-DDDB-4BE1-92CE-7C5172F92B9EQ34042482-A4974F04-0AFA-43B7-897B-5954DA61B8D5Q34123729-F4643C97-282D-4B3F-92AC-3CC3500EF8BCQ34143623-E7D540A5-64FD-45F2-AD79-5E96901E8CD8Q34151147-3B1C0B04-3CF4-41D7-AA01-D2C7616E9F38Q34228581-62BFB513-F13A-41C5-88AC-A8783C1CD0ABQ34330068-96902437-C4A0-4689-B1B6-8B8EC23F3A0AQ34353313-DAB0273F-A900-4E9A-8625-B0A17BE76C51Q34545667-8E571640-E0FE-47A0-84CF-86C097EADE60Q35143811-6D356551-374A-4FDE-B0E1-021312D76376Q35690694-72BD2EF9-A8DE-4FF5-B91A-537BAFD95B74Q35970087-046857D6-5734-45C9-BC7D-7151A5A9269FQ36025852-588562CC-7F78-4DFD-92CD-A7F74E98EED2Q36186792-2B30E1ED-511F-4986-B10F-75B60FFC8D6CQ36658623-A94F3B34-3550-4351-AF3D-DB7DD7935A1BQ37027505-F4482F0A-611D-46CB-A238-6FB294D78467Q37145300-E568473A-F804-4937-86C4-982F39B6905BQ37316282-611F944D-88C5-4296-B657-1928280802A4Q38807796-071C41AB-5157-41D2-966D-114D24E0D3FAQ38847960-4AF2E505-FB03-45EB-8225-9111F02CE15CQ39752604-FA44B0FA-4C11-406F-8EF9-AB56F0FBE795Q39797242-88315C50-52F5-4E43-9DD1-EBAC319D18B5Q40444302-F8AFB7DF-140C-4F3B-B436-24FE156BA4AAQ40535718-FC62CA5C-CC47-42C9-9EA9-F33190BCC686Q40632749-C9B63B2B-3280-4DDE-BD8B-E3D70BB15938Q40934476-A04D717D-1C1E-4433-B401-4746C2B32A54Q41209153-C7F80445-CDA5-4CC1-81E4-5E19698E4668Q41865790-3E74BD46-4AFE-41E4-9DC9-68556F79D1CCQ42559283-A715070E-AC53-40FD-B3EC-B1CEA749A617Q44232035-0304B502-3920-40D2-87E0-EFAFD7A226E6Q44560680-F0A94D1E-C943-485E-9D54-4C19E14BC3C0Q50802799-F9E7D14E-3759-425D-915B-4D3AE19E231EQ54746857-D27B4AC2-9D58-4D62-86DB-4BDEFF34559D
P2860
description
1997 nî lūn-bûn
@nan
1997 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մարտին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Adenovirus infections in immunocompromised patients.
@ast
Adenovirus infections in immunocompromised patients.
@en
type
label
Adenovirus infections in immunocompromised patients.
@ast
Adenovirus infections in immunocompromised patients.
@en
prefLabel
Adenovirus infections in immunocompromised patients.
@ast
Adenovirus infections in immunocompromised patients.
@en
P1476
Adenovirus infections in immunocompromised patients.
@en
P2093
Carrigan DR
P356
10.1016/S0002-9343(97)00015-6
P407
P577
1997-03-01T00:00:00Z